Browse Title Index
Issue Title
Vol 10, Supp. C (2019) Długotrwałe odpowiedzi na leczenie brentuksymabem vedotin u chorych na chłoniaka Hodgkina oraz chłoniaka anaplastycznego z dużych komórek Abstract
Andrzej Pluta
Vol 5, No 1 (2014) Early post-transplantation lymphoproliferative disorder with central nervous system involvement and EBV infection following allogeneic hematopoietic stem cells transplantation Abstract   PDF (Polish)   HTML (Polish)
Barbara Nasiłowska-Adamska, Piotr Grabarczyk, Tomasz Dzieciątkowski, Jerzy Windyga, Anna Ejduk, Agnieszka Tomaszewska, Andrzej Szczepiński, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Kazimierz Hałaburda, Bożena Mariańska, Krzysztof Warzocha
Vol 10, No 2 (2019) Editorial Details   PDF (Polish)
Iwona Hus
Vol 11, Supp. A (2020) Editorial Details   PDF (Polish)
Iwona Hus
Vol 11, No 3 (2020) Editorial Details   PDF (Polish)
Iwona Hus
Vol 12, Supp. C (2021) Effective midostaurin treatment in a patient with aggressive systemic mastocytosis Abstract   PDF (Polish)
Karolina Chromik, Patrycja Rozwadowska, Grzegorz Helbig
Vol 12, No 2 (2021) Effective midostaurin treatment in a patient with aggressive systemic mastocytosis Abstract   PDF
Karolina Chromik, Patrycja Rozwadowska, Grzegorz Helbig
Vol 9, No 1 (2018) Effective rescue treatment with tyrosine kinase inhibitors of a patient with B-cell acute lymphoblastic leukemia Philadelpha-positive Abstract   PDF (Polish)
Ilona Seferyńska, Anna Ejduk, Iwona Solarska, Krzysztof Warzocha
Vol 14 (2023): Continuous Publishing Effective treatment of severe forms of RSV and Pneumocystis jirovecii infections in a child with Down syndrome and acute lymphoblastic leukemia treated with chemotherapy Abstract   PDF   HTML
Magdalena Ostojska, Katarzyna Karska, Monika Lejman, Joanna Zawitkowska
Vol 12, No 1 (2021) Effectiveness and safety of ixazomib–lenalidomide–dexamethasone in high-cytogenetic-risk relapsed/refractory multiple myeloma — results of the Polish Myeloma Group observational study Abstract   PDF
Marek Hus, Aneta Szudy-Szczyrek, Michał Mielnik, Paweł Leszek Bernatowicz, Jarosław Piszcz, Agnieszka Druzd-Sitek, Maria Czyżewska, Maciej Putowski, Krzysztof Giannopoulos
Vol 12, Supp. D (2021) Effectiveness of combined therapy with midostaurin and standard chemotherapy and high dose chemotherapy with allogeneic stem cell transplantation in high risk acute myeloid leukemia with FLT3-TKD and NPM1 mutations Abstract   PDF
Elżbieta Patkowska, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Barbara Nasiłowska-Adamska
Vol 2, No 2 (2011) Effectiveness of minimal dose of lenalidomide in the treatment of relapsed plasma cell myeloma Abstract   PDF (Polish)
Hanna Ciepłuch, Jan Maciej Zaucha
Vol 11, No 4 (2020) Effectiveness of pomalidomide therapy in patient with multiple myeloma refractory to other immunomodulatory drugs Abstract   PDF (Polish)
Marta Masternak, Marta Morawska
Vol 8, Supp. C (2017) Effectiveness of ruxolitinib in the treatment of patients with myelofibrosis with co-morbidities Abstract   PDF (Polish)
Katarzyna Kotwica-Mojzych, Iwona Hus, Barbara Jodłowska-Jędrych, Mariusz Mojzych, Marek Hus
Vol 4, No 3 (2013) Effi cacy of primary myelofi brosis therapy with JAK2 inhibitors Abstract   PDF (Polish)   HTML (Polish)
Tomasz Sacha
Vol 8, Supp. A (2017) Efficacy and safety of long-term pomalidomide treatment in a patient with relapsed/refractory plasma cell myeloma — case report Abstract   PDF (Polish)
Grzegorz Charliński, Elżbieta Wiater
Vol 5, No 4 (2014) Efficacy and safety of tyrosine kinase inhibitors in elderly patients with chronic myelogenous leukemia Abstract   PDF (Polish)   HTML (Polish)
Krzysztof Lewandowski
Vol 1, No 4 (2010) Efficacy of bendamustine combined with rituximab in the treatment of relapsed chronic lymphocytic leukemia Abstract   PDF (Polish)
Wioletta Kamińska, Maria Luiza Kusz, Iwona Hus
Vol 5, No 2 (2014) Efficacy of bendamustine combined with rituximab in the treatment of relapsed follicular lymphoma — a case report and review of the literature Abstract   PDF (Polish)   HTML (Polish)
Agata Malenda, Agnieszka Kołkowska-Leśniak, Ewa Lech-Marańda, Krzysztof Warzocha
Vol 10, Supp. C (2019) Efficacy of brentuximab vedotin in the fourth-line treatment of primary resistant Hodgkin lymphoma Abstract   PDF (Polish)
Beata Kania-Zembaczyńska
Vol 12, No 1 (2021) Efficacy of lenalidomide in the treatment of myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) with the presence of deletion 5q– and trisomy 8+ Abstract   PDF
Oliwia Bachanek-Mitura, Aneta Szudy-Szczyrek, Marek Hus
Vol 13, No 1 (2022) Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features Abstract   PDF
Elżbieta Patkowska, Monika Prochorec-Sobieszek, Ewa Lech-Marańda, Barbara Nasiłowska-Adamska
Vol 2, No 1 (2011) Efficacy of rituximab in refractory primary immune thrombocytopenia Abstract   PDF (Polish)
Agnieszka Kopacz
Vol 12, Supp. B (2021) Eltrombopag in the treatment of patient with immune thrombocytopenia and atrial fibrillation Abstract   PDF (Polish)
Michał Witkowski, Magdalena Witkowska, Tadeusz Robak
Vol 12, Supp. B (2021) Eltrombopag in the treatment of pediatric chronic immune thrombocytopenia — a single-center experience Abstract   PDF (Polish)
Joanna Bulsa, Aneta Pobudejska-Pieniążek, Agnieszka Książek, Tomasz Szczepański
126 - 150 of 543 Items <<   <   1 2 3 4 5 6 7 8 9 10   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl